Analytical Data
-
Gene name
ACOT13
- Application
-
Alternative Names
rHuAcyl-coenzyme A thioesterase 13, His; ACOT-13; Acyl-coenzyme A thioesterase 13
-
Species
Human
-
Source
HEK293
-
Tag
C-6*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NPJ3-1
-
Expression Region
T2-N140
-
Protein Length
Full Length of Mature Protein
-
Molecular Weight
15.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACOT13, or acyl-CoA thioesterase 13, is a member of the acyl-CoA thioesterase family, which plays a crucial role in lipid metabolism by hydrolyzing acyl-CoA esters into free fatty acids and CoA. This enzyme has garnered attention due to its involvement in various physiological processes, including energy homeostasis, inflammation, and cellular signaling. Studies have shown that ACOT13 can modulate cellular lipid levels, potentially influencing metabolic disorders such as obesity and diabetes. Furthermore, its expression is regulated by diverse stimuli including hormones and dietary factors, suggesting a role in adaptive responses to metabolic changes. The exploration of ACOT13 not only provides insights into basic biochemistry but also holds therapeutic potential, as targeting this enzyme could lead to novel strategies for managing metabolic diseases. Understanding the structure and function of ACOT13 through biochemical and molecular studies may offer a pathway to uncover its mechanistic roles in health and disease, paving the way for future clinical applications.
